Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness
- Study Title
- Glatiramer Acetate (Copaxoneֲ®) Study to Follow Participants From the First Original Study for Safety and Effectiveness
- Teva Identifier
- GA-9004 | 01-9004
- ClinicalTrials.gov Identifier
- NCT00203021
- Study Status
- Completed
- Trial Condition(s)
- Relapsing-Remitting Multiple Sclerosis
- Interventions
- Drug: Glatiramer acetate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- March 26, 1994 - February 28, 2018
- Phase
- Phase 4
